This Amedeo Smart survey is supported by Pfizer Oncology.
AmedeoBreast Cancer |
Free Subscription
Cancer Lett |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
CNTF axis to promote progression of brain metastases.&body=SIRKISOON SR, Wong GL, Aguayo NR, Doheny DL, et al. Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2-->CNTF axis to promote progression of brain metastases. Cancer Lett. 2022 May 16:215726. doi: 10.1016/j.canlet.2022.215726. https://www.ncbi.nlm.nih.gov/m/pubmed/35589002" ALT="Email" TITLE="Email"> --> >> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
>> Share |
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016